Latest Materials News

New Murchison Gold Limited has reported a robust start to production at its Crown Prince Gold Mine, with significant ore processed and first revenue expected in October 2025.

Challenger Gold has secured the final Environmental Impact Assessment amendment for its Hualilán Gold Project, enabling ore haulage and toll milling at the Casposo plant. This milestone unlocks a low-capital pathway to early cash flow while advancing the project’s development.

Metal Bank Limited has announced a non-renounceable entitlement offer to raise approximately $2.32 million, partially underwritten, to fund its Western Australia gold strategy and Queensland graphite exploration. The offer closes on 31 October 2025 and coincides with a strategic acquisition of gold assets from Hastings Technology Metals.

Native Mineral Resources has generated over $3 million in cash from September gold sales at its Blackjack operation, marking a key milestone as it prepares to shift to higher-grade ore processing in October.

Power Minerals confirms a high-grade carbonatite hard rock intrusion at its Santa Anna Rare Earth Elements Project in Brazil, with promising grades and ongoing drilling aimed at defining a maiden resource estimate.

Metals Australia Ltd reveals a 3.3-fold increase in its Lac Carheil graphite resource alongside promising assay results for precious and base metals, setting the stage for value-added by-product recovery.

Somerset Minerals reports multiple wide zones of visible copper mineralisation from Phase-2 drilling at its Coppermine Project in Nunavut, Canada, with assays pending. The results extend known mineralisation over 150m below surface and set the stage for a major drilling scale-up.

Athena Resources has reported outstanding assay and metallurgical results from its Byro South drilling program, revealing high-quality magnetite mineralisation with iron grades exceeding 68%. The company is now advancing towards a maiden resource estimate that could reshape the economics of its Byro Magnetite Project.

Southern Palladium has responded to an ASX price query denying undisclosed information behind its recent share price rise, instead pointing to positive commodity price trends and ongoing project developments.

Bio-Gene Technology Limited has addressed ASX concerns over the timing of its announcement on promising Flavocide efficacy data, confirming compliance with continuous disclosure rules after receiving final presentation materials from Purdue University.

Australian Clinical Labs has reached a $6.2 million settlement with the Australian Information Commissioner to resolve a Federal Court case stemming from a 2022 cyberattack on its newly acquired Medlab Pathology business.

OncoSil Medical has affirmed the materiality of the PANCOSIL Phase 1-2 trial results and detailed its compliance with ASX disclosure rules following the data presentation at CIRSE 2025.